KALA · KALA BIO, Inc. · Exempt Offerings
$2.71
-0.31 (-10.28%)
At close · Nov 20
Return incl. dividend (before tax)
Q2 2022 earnings call transcript
Market Cap
$1.74M
Shares
644,660
Volume · Nov 20
19.23K
Avg daily vol (5 sessions)
17.3K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-03-17 | New | Pharmaceuticals | $1,753,500 | $1,753,500 | 06b |
| 2026-02-13 | New | Biotechnology | $4,200,000 | $2,250,600 | 06b |
| 2024-12-31 | New | Biotechnology | $10,749,667 | $10,749,667 | 06b |
| 2024-06-28 | New | Biotechnology | $12,499,192 | $12,499,192 | 06b |
| 2021-11-29 | New | Biotechnology | $36,522,541 | $16,122,541 | 06b |
Showing 1–5 of 5 filings
Key facts
CIK
1479419
CUSIP
483119301
13F (30d)
23 filings
19 filers
Visit website
Investor relations